The agreement demonstrates the ability of the newly acquired complex diagnostic laboratory to promote national Empower COVID-19 testing systems for corporate clients, adding film and television studios, companies and universities.
VANCOUVER BC / ACCESSWIRE / October 7, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt: 8EC) (OTCQB: EPWCF) (“Empower” or “Company”) is pleased to announce that its new acquisition and total ownership The subsidiary, Kai Medical Laboratory, LLC (“KAI”), has introduced a COVID-19-PCR program for a film production. The program is expected to get 1,000 samples for 30 days.
THE NEWLY ACQUIRED KAI MEDICAL LABORATORY HAS PROCESSED TESTS FOR SIX FILM AND TELEVISION PRODUCTS ON THIS CHANNEL
On September 1, 2020, KAI entered into a service agreement with To Dream A Life, LLC, which supplies coordinated COVID-19 testing facilities in key US markets. Adding Los Angeles, Atlanta, New York, Dallas and other major U. S. cities. But it’s not the first time Through its Capsule Prevention Department https: //preventionpods. com. KAI has already tested for six other film and television productions through this data and continues to build acceptance and credibility within the industry.
The corporate extra reports that conversations are already taking place with prevention modules to potentially increase the number and duration of verification systems for the film and television industry once the existing 1000-sample program has been fortunately completed. Transactions of any kind have been shown but remain prudently positive given the good luck of dating to date.
“Anticipating the final touch of Kai Medical acquisition, we have taken advantage of significant opportunities in primary sectors such as film and television, supporting our Get Back To Work verification initiative,” said Steven McAuley, President and CEO of Empower. “Kai Medical has already created many check relationships that have the ability to generate significant gains in their ability to provide 24-hour check delivery processing times, making sure giant industries can effectively get back to work.
FILM AND TELEVISION STUDIOS ARE LOOKING FOR FAST AND RELIABLE TEST SOLUTIONS TO RESUME SAFE OPERATIONS AND LET GO BILLIONS OF LOSSES
In 2019, Disney was the first film studio in North America. With a record $3. 8 billion in the national box job, the study accounted for about 33% of this year’s gross cash workplace in the US. But it’s not the first time And Canada, or 38% considering Fox’s 20th Century Market Share. , which Disney acquired in early 2019.
In January 2020, U. S. sound and film recording was in the process of recording the U. S. But it’s not the first time It hired more than 456,000 people and several hundred thousand others in Canada, the UK and around the world.
As a result of coVID-19-like production closures and movie theater closures, most industry income and jobs have been temporarily lost and now face a significant threat of long-term damage if the industry cannot find answers that can provide resumption of operations.
Empower believes it will preferably be located through Kai Medical Laboratory to provide a detail of the overall solution with reliable, accurate and fast 24-hour COVID-19 RT-PCR testing, which are the most popular.
ABOUT EMPOWER
ABOUT Kai Medical Laboratory
Our project is to replace healthcare through cutting-edge science and quality care through the offering of value-added services, accuracy and consistency. Our unwavering commitment to quality compliance and clinical innovation elevates Kai’s medical lab to a new popularity in patient care. Dallas Medical District, near some of the largest health care teams in the United States, adding Parkland Hospital, UT Southwestern, Children’s Medical Center, Baylor Scott
ON BEHALF OF THE BOARD OF DIRECTORS:
NOTICE OF NON-LIABILITY FOR FUTURE STATEMENTS
This press release includes certain “forward-looking statements” or “forward-looking information” (collectively “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of ancient fact, are forward-looking statements and are based on expectations, estimates and projections as of the date of this press release. Forward-looking statements can be known through words such as “plans”, “continues”, “expects”, “plans”, “intends”, “believes”, “anticipates”, “estimates”, “possibly”, “”, “Prospective”, “proposed” and other similar words, or data that in certain occasions or situations “possibly” or “will happen”. The forward-looking statements contained in this press release include, but are not limited to, statements regarding: expected benefits to the Company and its shareholders from the acquisition of Kai Medical Laboratory; the terms of the transaction; the expected number of clinics and patients after closure; the long-term prospective good fortune of Kai Medical Laboratory, Sun Valley’s model of franchise; expected end date of the acquisition and its occurrence; and that the company will be poised to be a leading provider of services for complex patient wishes in 2020 and beyond. These statements are projections only, are based on assumptions that are known to control lately, and are subject to dangers and insecurities that may also cause actual results, performance or progress to differ materially from those contained in the forward-looking statements, in particular: The acquisition of Kai Medical Laboratory would possibly not end under the expected situations or not at all; that the company’s products may not perform as expected; that the Company could not possibly expand testing for COVID-19; while legislative adjustments are likely to have an adverse effect on the company’s operations and product development; that the company may not be able to offload good enough financing to carry out its business plan; general commercial, economic, competitive, political and social insecurities; not download the required approvals in connection with the proposed transaction; and other points beyond the control of society. No forward-looking statements can be guaranteed that any of the expected occurrences will occur or, if they do, what benefits the Company will derive from them. Readers are cautioned not to improperly rely on the forward-looking statements in this press release, which are qualified in their entirety through those cautionary statements. The Company has no obligation, and expressly disclaims any objective or obligation, to update or revise any forward-looking statement contained in this press release, whether as a result of new data, long-term occasions or otherwise, unless in cases expressly required through applicable laws.
SOURCE: Empower Clinics Inc.